BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12020354)

  • 1. Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.
    Gentzsch M; Aleksandrov A; Aleksandrov L; Riordan JR
    Biochem J; 2002 Sep; 366(Pt 2):541-8. PubMed ID: 12020354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.
    Aleksandrov L; Mengos A; Chang X; Aleksandrov A; Riordan JR
    J Biol Chem; 2001 Apr; 276(16):12918-23. PubMed ID: 11279083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.
    Aleksandrov L; Aleksandrov AA; Chang XB; Riordan JR
    J Biol Chem; 2002 May; 277(18):15419-25. PubMed ID: 11861646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
    Csanády L; Chan KW; Nairn AC; Gadsby DC
    J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
    Carson MR; Travis SM; Welsh MJ
    J Biol Chem; 1995 Jan; 270(4):1711-7. PubMed ID: 7530246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator production of a suitable protein for structural studies.
    Duffieux F; Annereau JP; Boucher J; Miclet E; Pamlard O; Schneider M; Stoven V; Lallemand JY
    Eur J Biochem; 2000 Sep; 267(17):5306-12. PubMed ID: 10951189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
    Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
    Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional similarities between the nucleotide-binding domains of CFTR and GTP-binding proteins.
    Carson MR; Welsh MJ
    Biophys J; 1995 Dec; 69(6):2443-8. PubMed ID: 8599650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain interdependence in the biosynthetic assembly of CFTR.
    Cui L; Aleksandrov L; Chang XB; Hou YX; He L; Hegedus T; Gentzsch M; Aleksandrov A; Balch WE; Riordan JR
    J Mol Biol; 2007 Jan; 365(4):981-94. PubMed ID: 17113596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
    Basso C; Vergani P; Nairn AC; Gadsby DC
    J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mg2+ -dependent ATP occlusion at the first nucleotide-binding domain (NBD1) of CFTR does not require the second (NBD2).
    Aleksandrov L; Aleksandrov A; Riordan JR
    Biochem J; 2008 Nov; 416(1):129-36. PubMed ID: 18605986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
    Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
    Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
    Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
    J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.
    Kloch M; Milewski M; Nurowska E; Dworakowska B; Cutting GR; Dołowy K
    Cell Physiol Biochem; 2010; 25(2-3):169-80. PubMed ID: 20110677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of sequences within the C-terminal domain of the cystic fibrosis transmembrane conductance regulator which impact maturation and stability.
    Gentzsch M; Riordan JR
    J Biol Chem; 2001 Jan; 276(2):1291-8. PubMed ID: 11022033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator.
    Schwiebert EM; Morales MM; Devidas S; Egan ME; Guggino WB
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2674-9. PubMed ID: 9482946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.
    Yang Z; Hildebrandt E; Jiang F; Aleksandrov AA; Khazanov N; Zhou Q; An J; Mezzell AT; Xavier BM; Ding H; Riordan JR; Senderowitz H; Kappes JC; Brouillette CG; Urbatsch IL
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1193-1204. PubMed ID: 29425673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.
    Chan KW; Csanády L; Seto-Young D; Nairn AC; Gadsby DC
    J Gen Physiol; 2000 Aug; 116(2):163-80. PubMed ID: 10919864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations.
    Vernon RM; Chong PA; Lin H; Yang Z; Zhou Q; Aleksandrov AA; Dawson JE; Riordan JR; Brouillette CG; Thibodeau PH; Forman-Kay JD
    J Biol Chem; 2017 Aug; 292(34):14147-14164. PubMed ID: 28655774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.